Counterfeits ruin party for drug dealers

By Vinod Guptan
The fight against counterfeit products, especially medicines, faces an uphill task. Most of the challenges involve complex and unfair trade practices that either infringe on individual company prospects or  precipitate adverse effects on investments and by extension public safety.

Other challenges emanate from a weak and inefficient regulatory framework that provide loopholes for unscrupulous persons keen on taking advantage of public demand for medicines to peddle counterfeited substances purely for purposes of making monetary gain.